½ÃÀ庸°í¼­
»óǰÄÚµå
1703482

Ç»½Ãµå»ê(Fusidic Acid) ½ÃÀå : »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø, ÆÇ¸Åä³Îº°(Á÷Á¢, °£Á¢), ÃÖÁ¾ ¿ëµµº°(³ó°¡Áø, ºÀ¿ÍÁ÷¿°, Àý»ó ¹× â»ó, ´«°¨¿°, ±âŸ), Áö¿ªº°, °æÀﺰ(2020-2030³â)

Fusidic Acid Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Sales Channel (Direct, Indirect), By End Use (Impetigo, Cellulitis, Cuts & Wounds, Eye Infection, Others), By Region and Competition, 2020-2030F

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: TechSci Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 185 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Ç»½Ãµå»ê ¼¼°è ½ÃÀåÀº 2024³â¿¡ 2,971¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2030³â¿¡´Â 4,212¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¿¹Ãø ±â°£ µ¿¾È 2.02%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ½ÃÀå ¼ºÀåÀº ƯÈ÷ ÇǺΠ¹× ¿¬Á¶Á÷¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ¼¼±Õ¼º °¨¿°ÁõÀÇ Ä¡·á¿¡¼­ Ç»½Ãµå»êÀÇ »ç¿ë È®´ë·Î ÀÎÇØ ²ÙÁØÈ÷ ¼ºÀåÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå °³¿ä
¿¹Ãø ±â°£ 2026-2030³â
½ÃÀå ±Ô¸ð : 2024³â 2,971¸¸ ´Þ·¯
½ÃÀå ±Ô¸ð : 2030³â 4,212¸¸ ´Þ·¯
CAGR : 2025-2030³â 2.02%
±Þ¼ºÀå ºÎ¹® Á÷Á¢
ÃÖ´ë ½ÃÀå ¾Æ½Ã¾ÆÅÂÆò¾ç

Ç»½Ãµå»êÀº ÁÖ·Î ¸ÞƼ½Ç¸° ³»¼º±Õ(MRSA)À» Æ÷ÇÔÇÑ È²»öÆ÷µµ»ó±¸±Õ¿¡ ÀÇÇÑ °¨¿°À» Ä¡·áÇÏ´Â µ¥ »ç¿ëµÇ´Â °­·ÂÇÑ Ç×»ýÁ¦·Î, ¿Ü¿ëÁ¦¿Í °æ±¸Á¦ ¸ðµÎ ÀϹÝÀûÀ¸·Î »ç¿ë °¡´ÉÇÏ¸ç º´¿ø°ú Áö¿ª»çȸ ¸ðµÎ¿¡¼­ ¿ì·ÁÀÇ ¸ñ¼Ò¸®°¡ Ä¿Áö°í ÀÖ½À´Ï´Ù. Ç×»ýÁ¦ ³»¼ºÀÌ Àü ¼¼°èÀûÀ¸·Î ½É°¢ÇÑ ¹®Á¦·Î ´ëµÎµÇ°í ÀÖ´Â °¡¿îµ¥, Ç»½Ãµå»ê°ú °°Àº È¿°úÀûÀÎ ´ëü ¾à¹°¿¡ ´ëÇÑ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

ÀÌ Ç×»ýÁ¦´Â ÀǾàǰ ¹× ÇǺΰú Á¦Á¦¿¡ ³Î¸® »ç¿ëµÇ¸ç, ƯÈ÷ Àü¿°¼º ³óÇÇÁõ, ¸ð³¶¿°, ºÀ¿ÍÁ÷¿°°ú °°Àº ÇǺΠÁúȯÀÇ Ä¡·á¿¡ ÁßÁ¡À» µÎ°í ÀÖ½À´Ï´Ù. ¼¼°è Àα¸ÀÇ °í·ÉÈ­¿Í ÇÔ²² ÀÌ·¯ÇÑ °¨¿°¼º ÁúȯÀÇ ¹ßº´·üÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ´Â ´Ù¾çÇÑ Áö¿ª¿¡¼­ Ǫ½Ãµò»ê¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Ç×»ýÁ¦ ³»¼º¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ Ç»½Ãµå»ê ±â¹Ý Ä¡·á¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ¼¼°è ½ÃÀå Æ¯Â¡Àº ºê·£µå ÀǾàǰ°ú Á¦³×¸¯ ÀǾàǰÀÌ È¥ÇյǾî ÀÖ´Ù´Â Á¡À̸ç, Á¦³×¸¯ ÀǾàǰÀº Àú·ÅÇÑ °¡°Ý°ú Æø³ÐÀº °¡¿ë¼ºÀ¸·Î ÀÎÇØ Á¡Á¡ ´õ ¸¹Àº ÁöÁö¸¦ ¹Þ°í ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ

¼¼°è ÇコÄÉ¾î »ê¾÷ÀÇ È®Àå

ÁÖ¿ä ½ÃÀå À̽´

¾ÈÀü¼º ¿ì·Á¿Í ºÎÀÛ¿ë

ÁÖ¿ä ½ÃÀå µ¿Çâ

¾È±¸°¨¿°Áõ Áõ°¡

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå COVID-19°¡ ¼¼°èÀÇ Ç»½Ãµå»ê ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâ

Á¦5Àå ¼¼°èÀÇ Ç»½Ãµå»ê ½ÃÀå Àü¸Á

  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø
    • ±Ý¾×º°
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
    • ÆÇ¸Åä³Îº°(Á÷Á¢, °£Á¢)
    • ¿ëµµº°(Àü¿°¼º ³ó°¡Áø, ºÀ¿ÍÁ÷¿°, Àý»ó, ´«°¨¿°Áõ, ±âŸ)
    • Áö¿ªº°
    • ±â¾÷º°(2024³â)
  • ½ÃÀå ¸Ê

Á¦6Àå ºÏ¹ÌÀÇ Ç»½Ãµå»ê ½ÃÀå Àü¸Á

  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
  • ºÏ¹Ì : ±¹°¡º° ºÐ¼®
    • ¹Ì±¹
    • ¸ß½ÃÄÚ
    • ij³ª´Ù

Á¦7Àå À¯·´ÀÇ Ç»½Ãµå»ê ½ÃÀå Àü¸Á

  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
  • À¯·´ : ±¹°¡º° ºÐ¼®
    • ÇÁ¶û½º
    • µ¶ÀÏ
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Ç»½Ãµå»ê ½ÃÀå Àü¸Á

  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
  • ¾Æ½Ã¾ÆÅÂÆò¾ç : ±¹°¡º° ºÐ¼®
    • Áß±¹
    • Àεµ
    • Çѱ¹
    • ÀϺ»
    • È£ÁÖ

Á¦9Àå ³²¹ÌÀÇ Ç»½Ãµå»ê ½ÃÀå Àü¸Á

  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
  • ³²¹Ì : ±¹°¡º° ºÐ¼®
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • ÄÝ·Òºñ¾Æ

Á¦10Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ Ç»½Ãµå»ê ½ÃÀå Àü¸Á

  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ±¹°¡º° ºÐ¼®
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)

Á¦11Àå ½ÃÀå ¿ªÇÐ

  • ¼ºÀå ÃËÁø¿äÀÎ
  • °úÁ¦

Á¦12Àå ½ÃÀå µ¿Çâ°ú ¹ßÀü

  • ÀμöÇÕº´(M&A)
  • Á¦Ç° Ãâ½Ã
  • ÃÖ±Ù µ¿Çâ

Á¦13Àå ¼¼°èÀÇ Ç»½Ãµå»ê ½ÃÀå : SWOT ºÐ¼®

Á¦14Àå PorterÀÇ Five Forces ºÐ¼®

  • ¾÷°è³» °æÀï
  • ½Å±Ô Âü¿© °¡´É¼º
  • °ø±Þ¾÷üÀÇ Èû
  • °í°´ÀÇ Èû
  • ´ëüǰÀÇ À§Çù

Á¦15Àå °æÀï ±¸µµ

  • Ercros S.A
  • Emote Life sciences LLP
  • Kaniwa Bioscience Pvt. Ltd
  • Concord Biotech Limited
  • Fleming Laboratories Ltd
  • Sterling Biotech Ltd
  • Oliver Pharmaceuticals
  • Apex Healthcare Ltd
  • Horster Life Sciences Pvt. Ltd.
  • Celaxis Bioscience Pvt Ltd

Á¦16Àå Àü·«Àû Á¦¾È

Á¦17Àå ¸®¼­Ä¡»ç¿¡ ´ëÇØ & ¸éÃ¥»çÇ×

LSH 25.04.25

Global Fusidic Acid Market was valued at USD 29.71 million in 2024 and is projected to reach USD 42.12 million by 2030, growing at a compound annual growth rate (CAGR) of 2.02% over the forecast period. Market growth is being steadily driven by the increasing application of fusidic acid in treating bacterial infections, particularly those affecting the skin and soft tissues.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 29.71 Million
Market Size 2030USD 42.12 Million
CAGR 2025-20302.02%
Fastest Growing SegmentDirect
Largest MarketAsia-Pacific

Fusidic acid is a potent antibiotic commonly available in both topical and oral formulations, primarily used to treat infections caused by Staphylococcus aureus, including methicillin-resistant strains (MRSA), which are a growing concern in both hospital and community settings. As antibiotic resistance becomes an escalating global issue, the need for effective alternatives such as fusidic acid is gaining momentum.

This antibiotic is widely used in pharmaceutical and dermatological formulations, with a particular focus on treating skin conditions like impetigo, folliculitis, and cellulitis. The rising incidence of these infections, coupled with an aging global population, is fueling demand for fusidic acid across various geographies. Additionally, heightened awareness surrounding antibiotic resistance has intensified interest in fusidic acid-based treatments. The global market is characterized by a mix of branded and generic products, with generic formulations increasingly gaining traction due to their affordability and broader availability.

Key Market Drivers

Expansion of the Global Healthcare Industry

The ongoing growth of the global healthcare sector is a significant catalyst for the fusidic acid market. Worldwide healthcare sales are projected to surpass USD 4 trillion annually, with pharmaceuticals and biotechnology representing the most substantial segments-generating close to USD 850 billion-followed by medical technology and diagnostics at over USD 400 billion.

Fusidic acid is recognized as a valuable therapeutic solution for a range of bacterial infections, including skin, eye, and soft tissue infections. As the demand for targeted and effective treatments rises, driven by the increasing incidence of bacterial infections and improvements in healthcare infrastructure and accessibility, the market for fusidic acid continues to expand.

Key Market Challenges

Safety Concerns and Adverse Effects

One of the primary concerns surrounding the use of fusidic acid is its potential hepatotoxicity. Prolonged use or high dosages can lead to liver complications such as hepatitis or jaundice-particularly in patients with existing liver conditions, thereby increasing the risk of adverse reactions. As a result, patients undergoing treatment with fusidic acid often require regular liver function monitoring to mitigate risks.

These safety considerations limit the duration for which fusidic acid can be prescribed, posing challenges in cases that demand long-term antibiotic therapy. In addition, while topical formulations are widely used for skin infections, they can cause local side effects such as irritation, redness, itching, or rashes-sometimes resulting in treatment discontinuation among sensitive individuals.

Although rare, allergic reactions-including severe responses such as anaphylaxis-can occur, especially in immunocompromised populations. These potential risks may hinder wider market adoption. To address this, manufacturers must implement clear labeling, patient education, and effective monitoring practices to ensure safe and informed usage.

Key Market Trends

Rising Incidence of Eye Infections

A notable trend propelling the global fusidic acid market is the increasing prevalence of bacterial eye infections. According to the World Health Organization (WHO), trachoma alone is responsible for approximately 1.9 million cases of blindness or visual impairment across 42 countries, representing 1.4% of global blindness. The economic burden associated with this condition is estimated between USD 2.9 billion and USD 5.3 billion annually.

Bacterial eye infections caused by pathogens such as Staphylococcus aureus and Streptococcus pneumoniae are on the rise due to several factors, including environmental pollution, rapid urbanization, and lifestyle-related changes. Fusidic acid, known for its efficacy in treating localized bacterial infections, has emerged as a key solution for conditions such as bacterial conjunctivitis, blepharitis, and keratitis.

This upward trend is further supported by increasing exposure to environmental irritants, allergens, and extended screen time, all of which contribute to eye dryness and a higher risk of infection. Additionally, the growing global use of contact lenses-particularly in urban populations-has led to a rise in bacterial eye infections linked to poor hygiene and prolonged wear. These factors are driving the demand for fusidic acid-based ophthalmic treatments, reinforcing its role in the evolving landscape of infectious disease management.

Key Market Players

  • Ercros S.A
  • Emote Life sciences LLP
  • Kaniwa Bioscience Pvt. Ltd
  • Concord Biotech Limited
  • Fleming Laboratories Ltd
  • Sterling Biotech Ltd
  • Oliver Pharmaceuticals
  • Apex Healthcare Ltd
  • Horster Life Sciences Pvt. Ltd.
  • Celaxis Bioscience Pvt Ltd

Report Scope

In this report, the Global Fusidic Acid Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Fusidic Acid Market, By Sales Channel:

  • Direct
  • Indirect

Fusidic Acid Market, By End Use:

  • Impetigo
  • Cellulitis
  • Cuts & Wounds
  • Eye Infection
  • Others

Fusidic Acid Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Fusidic Acid Market.

Available Customizations:

Global Fusidic Acid Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Impact of COVID-19 on Global Fusidic Acid Market

5. Global Fusidic Acid Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Sales Channel (Direct, Indirect)
    • 5.2.2. By End Use (Impetigo, Cellulitis, Cuts & Wounds, Eye Infection, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Fusidic Acid Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Sales Channel
    • 6.2.2. By End Use
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Fusidic Acid Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Sales Channel
        • 6.3.1.2.2. By End Use
    • 6.3.2. Mexico Fusidic Acid Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Sales Channel
        • 6.3.2.2.2. By End Use
    • 6.3.3. Canada Fusidic Acid Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Sales Channel
        • 6.3.3.2.2. By End Use

7. Europe Fusidic Acid Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Sales Channel
    • 7.2.2. By End Use
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Fusidic Acid Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Sales Channel
        • 7.3.1.2.2. By End Use
    • 7.3.2. Germany Fusidic Acid Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Sales Channel
        • 7.3.2.2.2. By End Use
    • 7.3.3. United Kingdom Fusidic Acid Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Sales Channel
        • 7.3.3.2.2. By End Use
    • 7.3.4. Italy Fusidic Acid Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Sales Channel
        • 7.3.4.2.2. By End Use
    • 7.3.5. Spain Fusidic Acid Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Sales Channel
        • 7.3.5.2.2. By End Use

8. Asia Pacific Fusidic Acid Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Sales Channel
    • 8.2.2. By End Use
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Fusidic Acid Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Sales Channel
        • 8.3.1.2.2. By End Use
    • 8.3.2. India Fusidic Acid Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Sales Channel
        • 8.3.2.2.2. By End Use
    • 8.3.3. South Korea Fusidic Acid Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Sales Channel
        • 8.3.3.2.2. By End Use
    • 8.3.4. Japan Fusidic Acid Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Sales Channel
        • 8.3.4.2.2. By End Use
    • 8.3.5. Australia Fusidic Acid Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Sales Channel
        • 8.3.5.2.2. By End Use

9. South America Fusidic Acid Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Sales Channel
    • 9.2.2. By End Use
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Fusidic Acid Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Sales Channel
        • 9.3.1.2.2. By End Use
    • 9.3.2. Argentina Fusidic Acid Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Sales Channel
        • 9.3.2.2.2. By End Use
    • 9.3.3. Colombia Fusidic Acid Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Sales Channel
        • 9.3.3.2.2. By End Use

10. Middle East and Africa Fusidic Acid Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Sales Channel
    • 10.2.2. By End Use
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Fusidic Acid Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Sales Channel
        • 10.3.1.2.2. By End Use
    • 10.3.2. Saudi Arabia Fusidic Acid Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Sales Channel
        • 10.3.2.2.2. By End Use
    • 10.3.3. UAE Fusidic Acid Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Sales Channel
        • 10.3.3.2.2. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Fusidic Acid Market: SWOT Analysis

14. Porters Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Ercros S.A
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. Emote Life sciences LLP
  • 15.3. Kaniwa Bioscience Pvt. Ltd
  • 15.4. Concord Biotech Limited
  • 15.5. Fleming Laboratories Ltd
  • 15.6. Sterling Biotech Ltd
  • 15.7. Oliver Pharmaceuticals
  • 15.8. Apex Healthcare Ltd
  • 15.9. Horster Life Sciences Pvt. Ltd.
  • 15.10. Celaxis Bioscience Pvt Ltd

16. Strategic Recommendations

17. About Us & Disclaimer

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦